LabMedica

Download Mobile App
Recent News Expo ADLM 2026 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

U.S. Navy Purchases Dry-Hematology Analyzers

By LabMedica International staff writers
Posted on 07 Sep 2010
The United States Navy is installing hematology analyzers on surface ships throughout the world.

The QBC STAR hematology analyzers provide users a nine-parameter complete blood count through its dry-hematology approach, which eliminates the need for liquid reagents. Because of this technology, as well as the unit's small footprint and internal calibration system, the STAR can be transported easily and provide accurate patient results within minutes.

"Our line of hematology products are especially well suited for use in the military environment," commented Ken Moscone, president and CEO of QBC Diagnostics (Port Matilda, PA, USA). "With one-button operation, no start-up requirements, and the use of simple blood collection tubes, the STAR is robust, designed to go anywhere and provide results quickly. Unlike liquid reagents, dry QBC technology is not adversely affected by the pitch and roll of a ship, making it especially well-suited for use on Navy vessels."

QBC Diagnostics is a privately held company that manufactures a line of complete blood count analyzers and fluorescence microscopy products.

Related Links:

QBC Diagnostics









Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Online QC Software
Acusera 24•7
Prefilled Tubes
Prefilled 5.0ml Tubes
Multi-Chamber Washer-Disinfector
WD 390

Latest Industry News

Collaboration Advances Extracellular Vesicle-Based Tests for Neurodegenerative Diseases
07 Sep 2010  |   Industry

Tempus to Acquire Personalis in $1.5 Billion Precision Oncology Deal
07 Sep 2010  |   Industry

Bruker Expands NGS Capabilities for Sepsis and Bloodstream Infections
07 Sep 2010  |   Industry



PURITAN MEDICAL